Oekolp (Estriol)

Estriol, the active ingredient in Oekolp, is an estrogen presented as a tablet for oral use. It treats menopausal symptoms and is used in hormone replacement therapy for postmenopausal women. GNH USA supplies Oekolp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oekolp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oekolp is an estrogen medication that acts on hormonal pathways involved in menopause and related conditions. - Menopausal vasomotor symptoms: Reduces the frequency and severity of hot flashes. - Genitourinary syndrome of menopause: Improves vaginal dryness and discomfort. - Osteopenia prevention: Contributes to maintenance of bone mineral density in post‑menopausal women.

Adverse reactions to Oekolp are generally mild and reversible.

Common Side Effects: - Nausea - Breast tenderness - Headache - Bloating - Mood changes - Vaginal spotting

Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Endometrial hyperplasia - Liver function abnormalities - Allergic reactions (rash, angioedema)

Before using Oekolp, consider the following safety measures: - Contraindications: Do not use if you have a history of estrogen‑dependent tumors. - Cardiovascular risk: Assess risk for thromboembolic events. - Liver function: Monitor if hepatic impairment exists. - Breast cancer surveillance: Regular screening is advised. - Bone health: Evaluate baseline bone density. - Store at room temperature: keep the tablet in the original pack by …

Store ​ ​  ​  ":"  ""

The ​    ""     ""  "  "  "" ... 

"  "